Analyst Daniil Gataulin works at CHARDAN CAPITAL and is focused on the Healthcare sector with 12 price targets and ratings documented since 2022 spanning on 6 stocks.
Most recent stock forecast was given on ADVM, Adverum Biotechnologies, Inc at 11-Nov-2022.
Daniil Gataulin best performing recommendations are on KOD (KODIAK SCIENCES INC).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
2
$1.3 (185.71%)
2.5
2 months 24 days ago
0/2 (0%)
$1.13 (114.91%)
Hold
2
$1.3 (185.71%)
5
1 years 6 months 12 days ago
3/5 (60%)
$3.07 (29.73%)
47
Hold
3
$2.3 (328.57%)
21
1 years 6 months 12 days ago
4/5 (80%)
$3.63 (50.89%)
139
Hold
21
1 years 6 months 12 days ago
2/2 (100%)
$7.53 (88.83%)
197
Buy
6
$5.3 (757.14%)
30
1 years 9 months 6 days ago
1/3 (33.33%)
$4.81 (39.30%)
34